Trends in the use of radical prostatectomy for treatment of prostate cancer.

PubWeight™: 0.88‹?›

🔗 View Article (PMID 10623055)

Published in Eff Clin Pract on December 20, 1999

Authors

L M Ellison1, J A Heaney, J D Birkmeyer

Author Affiliations

1: Department of Surgery, Dartmouth-Hitchcock Medical Center, Hanover, NH, USA. lars.ellison@hitchcock.org

Articles by these authors

A regional intervention to improve the hospital mortality associated with coronary artery bypass graft surgery. The Northern New England Cardiovascular Disease Study Group. JAMA (1996) 7.35

Variation in carotid endarterectomy mortality in the Medicare population: trial hospitals, volume, and patient characteristics. JAMA (1998) 3.19

Patient preferences for location of care: implications for regionalization. Med Care (1999) 2.57

Potential reduction in mortality rates using an intensivist model to manage intensive care units. Eff Clin Pract (2001) 2.35

Cost-effectiveness of cardioversion and antiarrhythmic therapy in nonvalvular atrial fibrillation. Ann Intern Med (1999) 2.15

Managing chronic atrial fibrillation: a Markov decision analysis comparing warfarin, quinidine, and low-dose amiodarone. Ann Intern Med (1994) 2.10

Tissue-shrinkage correction factor in the calculation of prostate cancer volume. Am J Surg Pathol (1996) 2.06

Operative mortality with elective surgery in older adults. Eff Clin Pract (2001) 2.06

The epidemiology of diagnosed pulmonary embolism and deep venous thrombosis in the elderly. Arch Intern Med (1994) 1.96

Case mix, quality and high-cost kidney transplant patients. Am J Transplant (2009) 1.79

Effect of preoperative aspirin use on mortality in coronary artery bypass grafting patients. Ann Thorac Surg (2000) 1.78

The cost-effectiveness of treating all patients with type 2 diabetes with angiotensin-converting enzyme inhibitors. Ann Intern Med (1999) 1.73

Safety of the blood supply in the United States: opportunities and controversies. Ann Intern Med (1997) 1.71

Safety and cost-effectiveness of solvent-detergent-treated plasma. In search of a zero-risk blood supply. JAMA (1994) 1.67

The effect of hospital volume on mortality and resource use after radical prostatectomy. J Urol (2000) 1.60

Acute normovolemic hemodilution is a cost-effective alternative to preoperative autologous blood donation by patients undergoing radical retropubic prostatectomy. Transfusion (1995) 1.59

Cardiologists performing peripheral angioplasties: impact on utilization. Eff Clin Pract (2001) 1.56

A prospective study comparing the complication rates between laparoscopic and open ventral hernia repairs. Surg Endosc (2003) 1.49

Cost-effectiveness of head CT in patients with lung cancer without clinical evidence of metastases. Chest (1995) 1.45

The effects of donor and recipient practices on transplant center finances. Am J Transplant (2008) 1.44

Giant cyst of the seminal vesicle with renal agenesis. AJR Am J Roentgenol (1987) 1.43

Cost-effectiveness analysis in surgery. Surgery (1998) 1.40

Electrical property sensing biopsy needle for prostate cancer detection. Prostate (2013) 1.39

Cost-effectiveness of surgery for small abdominal aortic aneurysms on the basis of data from the United Kingdom small aneurysm trial. J Vasc Surg (2000) 1.38

Effect of coronary artery diameter in patients undergoing coronary bypass surgery. Northern New England Cardiovascular Disease Study Group. Circulation (1996) 1.33

Reexploration for hemorrhage following coronary artery bypass grafting: incidence and risk factors. Northern New England Cardiovascular Disease Study Group. Arch Surg (1998) 1.28

Prosthetic valve type for patients undergoing aortic valve replacement: a decision analysis. Ann Thorac Surg (2000) 1.27

In vivo description of dendritic cells in human renal cell carcinoma. J Urol (1999) 1.23

Metastatic renal cell carcinoma presenting as a skin nodule: case report and review of the literature. J Urol (1994) 1.21

National trends in utilization and outcomes of antireflux surgery. Surg Endosc (2003) 1.18

Cost-effectiveness of carotid endarterectomy in asymptomatic patients. J Vasc Surg (1997) 1.14

Variation in the use of laparoscopic cholecystectomy for elderly patients with acute cholecystitis. Arch Surg (2000) 1.13

Cost-effectiveness of expanded human immunodeficiency virus-testing protocols for donated blood. Transfusion (1997) 1.09

High-risk surgery--follow the crowd. JAMA (2000) 1.08

Laparoscopy may be lowering the threshold to operate on patients with suspected appendicitis. Surg Endosc (2002) 1.08

Results of a regional study of modes of death associated with coronary artery bypass grafting. Northern New England Cardiovascular Disease Study Group. Ann Thorac Surg (1998) 1.05

Should endovascular surgery lower the threshold for repair of abdominal aortic aneurysms? J Vasc Surg (1999) 1.01

The Dartmouth Atlas of Vascular Health Care. Cardiovasc Surg (2000) 1.00

Is epsilon-aminocaproic acid as effective as aprotinin in reducing bleeding with cardiac surgery?: a meta-analysis. Circulation (1999) 0.95

A randomized phase II trial comparing two different sequence combinations of autologous vaccine and human recombinant interferon gamma and human recombinant interferon alpha2B therapy in patients with metastatic renal cell carcinoma: clinical outcome and analysis of immunological parameters. J Urol (2000) 0.94

Vulvar metastases secondary to transitional cell carcinoma of the bladder. A case report. J Reprod Med (1999) 0.93

The effect of intravesical thio-tepa on normal and tumor urothelium. J Urol (1978) 0.92

Adrenal insufficiency from bilateral adrenal hemorrhage after total knee replacement surgery. Urology (1997) 0.90

Nodal involvement as a prognostic indicator in patients with prostatic carcinoma. J Urol (1980) 0.90

Non-Hodgkin lymphoma arising in lower urinary tract. Urology (1985) 0.89

Efficacy versus effectiveness of carotid endarterectomy. Eff Clin Pract (1999) 0.89

Expression of Fas(APO-1/CD95) in tumor-infiltrating and peripheral blood lymphocytes in patients with renal cell carcinoma. Cancer Res (1998) 0.89

Fatal genitourinary mucormycosis in a patient with undiagnosed diabetes. Clin Infect Dis (1995) 0.89

Changes in patients undergoing coronary artery bypass grafting: 1987-1990. Northern New England Cardiovascular Disease Study Group. Ann Thorac Surg (1994) 0.88

Biopsy of apparently normal urothelium in patients with bladder carcinoma. J Urol (1978) 0.87

Prostate-specific antigen. Superior serum marker for prostatic carcinoma. Ir J Med Sci (1987) 0.86

Relation of surgical volume to outcome. Ann Surg (2000) 0.86

Value and cost-effectiveness of screening blood donors for antibody to hepatitis B core antigen as a way of detecting window-phase human immunodeficiency virus type 1 infections. The HIV Blood Donor Study Group. Transfusion (1997) 0.86

Pounds of prevention for ounces of cure: surgery as a preventive strategy. Lancet (1999) 0.85

Computed tomographic findings in renal angiomyolipoma: an histologic correlation. Urology (1984) 0.85

Efficacy and cost-effectiveness of autologous blood predeposit in patients undergoing radical prostatectomy procedures. Urology (1994) 0.85

Respiratory distress following cesarean section: cryptic presentation of bladder injury. Urology (1994) 0.84

Economic impact of inappropriate blood transfusions in coronary artery bypass graft surgery. Am J Med (1993) 0.84

Controversies in transfusion medicine. Is autologous blood transfusion worth the cost? Con. Transfusion (1994) 0.82

Psoas abscess following intravesical bacillus Calmette-Guerin for bladder cancer: a case report. J Urol (1993) 0.82

T-cell receptor zeta-chain expression on tumor-infiltrating lymphocytes from renal cell carcinoma. Cancer Res (1997) 0.82

Multifocal pigmentation of prostatic and bladder urothelium. J Urol (1986) 0.82

In vivo growth of human bladder cancer cell lines. Invest Urol (1978) 0.81

Staging of prostate cancer with endorectal MR imaging: lessons from a learning curve. Radiographics (1995) 0.80

Trends in rates of reexploration for hemorrhage after coronary artery bypass surgery. Northern New England Cardiovascular Disease Study Group. Ann Thorac Surg (1999) 0.80

Surgical treatment of verrucous carcinoma of the bladder unassociated with bilharzial cystitis: case report and literature review. J Urol (1995) 0.80

Theoretical and experimental analysis of air cooling for intracavitary microwave hyperthermia applicators. IEEE Trans Biomed Eng (1994) 0.80

Phase I pilot trial of the bispecific antibody MDXH210 (anti-Fc gamma RI X anti-HER-2/neu) in patients whose prostate cancer overexpresses HER-2/neu. J Immunother (2001) 0.79

Prognosis of clinically undiagnosed prostatic carcinoma and the influence of endocrine therapy. J Urol (1977) 0.79

Vicarious excretion of urographic contrast in a multiple trauma patient. Br J Urol (1987) 0.79

Nephrogenic adenoma and embryonic kidney tubules share PNA receptor sites. Am J Clin Pathol (1984) 0.78

Cell surface coat of human and rat bladder urothelium. I. Ruthenium-red studies in non-neoplastic and neoplastic cells. Virchows Arch B Cell Pathol Incl Mol Pathol (1983) 0.78

Retroperitoneal leiomyosarcoma: a rare cause of adrenal pseudotumor on CT and MRI. Urol Radiol (1988) 0.78

Lectins as a probe for carbohydrate residues in non-neoplastic urothelium of human urinary bladder. J Urol (1982) 0.78

Update of cost-effectiveness analysis for solvent-detergent-treated plasma. JAMA (1999) 0.77

A coaxial microwave applicator for transurethral hyperthermia of the prostate. Prostate (1993) 0.77

Hemorrhagic myelolipoma of adrenal gland after blunt trauma. Urology (1991) 0.76

Postoperative radiation therapy for muscle-invading bladder carcinoma. J Surg Oncol (1983) 0.76

Continuous infusion of intrathecal morphine to control acquired immunodeficiency syndrome-associated bladder pain. J Urol (1992) 0.76

Misuse of multivariate analysis. Surgery (1998) 0.75

Outcomes in vascular surgery: volume versus certification. Surgery (2001) 0.75

The learning curve for laparoscopic colorectal surgery. Arch Surg (1997) 0.75

Estimates of risk of posttransfusion hepatitis. Am J Med (1992) 0.75

Should physicians screen for mild thyroid failure? JAMA (1996) 0.75

Risk of breast cancer in carriers of BRCA gene mutations. N Engl J Med (1997) 0.75

Obstructive uropathy--a potentially serious complication of reconstructive vascular surgery. J Urol (1983) 0.75

Unusual renal mass in a middle-aged woman. J Urol (1983) 0.75

Rapid peroxidase-antiperoxidase method for determination of ABH tissue isoantigens. Stain Technol (1983) 0.75

Acute leukemia: diagnosis and management of testicular involvement. Urology (1983) 0.75

Urological injury and assessment in patients with pelvic fractures. R I Med J (1991) 0.75

The Björk-Shiley dilemma. Ann Thorac Surg (1993) 0.75

Prospective development of a cost-efficient program for the pubovaginal sling. Urology (1997) 0.75

Decision analysis for small, asymptomatic intracranial arteriovenous malformations. Neurosurg Focus (2001) 0.75

Segmental calculus disease: potential of parital nephrectomy. Urology (1981) 0.75

Use of inferior vena cava filters in the Medicare population. Ann Vasc Surg (1995) 0.75

Recurrent ileal conduit hemorrhage in an elderly cirrhotic man. J Urol (1994) 0.75

Diuretic renal scan: is it always reliable? J Endourol (1994) 0.75

Angiographic management of retroperitoneal hemorrhage from renal angiomyolipoma in polycystic kidney disease. J Urol (1991) 0.75

5-fluorouracil and allopurinol combined with recombinant interferon-alpha 2b in the treatment of patients with advanced prostate cancer: a phase I/II study. J Urol (1996) 0.75